ArticleChirurgie (Heidelberg, Germany)2025
[Update on follicular thyroid cancer-What is relevant for surgeons?]
Article in Chirurgie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular thyroid cancer (FTC) is the second most frequent form of differentiated thyroid cancer, accounting for approximately 5-15% of all thyroid malignancies. According to the World Health Organization (WHO) classification from 2022 FTC is divided into three subtypes, which clearly differ in the overall prognosis and probability of recurrence. Furthermore, knowledge about benign follicular tumors and low-grade neoplasms is important. Prognostic factors for malignant alterations include patient age, tumor size, invasive growth, the presence of angioinvasion and the occurrence of distant metastases. The surgical management is guided by these factors and therefore varies between the different FTC subtypes. In summary, a precise understanding of the individual subtypes of thyroid tumors is essential to be able to make an appropriate and personalized decision on surgical treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.